A time-motion study of the COVID-19 vaccination process in an urban primary health center of Odisha, India
- PMID: 35727159
- PMCID: PMC9359350
- DOI: 10.1080/21645515.2022.2073759
A time-motion study of the COVID-19 vaccination process in an urban primary health center of Odisha, India
Abstract
Vaccination is a critical tool in protecting against COVID-19. It is essential to know the time for each activity in a COVID-19 vaccination process for better management, especially during a pandemic. Thus, we conducted a time-motion study to identify activities that led to delayed/increased waiting time in an urban primary health center in Bhubaneswar, India. We observed 196 COVID-19 vaccine beneficiaries over one month (June 2021) from when they arrived at the vaccination center until they left the center. A data collection form and a Stopwatch were used to estimate the time taken for various activities involved in COVID-19 vaccine delivery. The time taken was expressed in mean and median. We also compared the time taken during the first and second doses using the Mann-Whitney U test. The total mean time spent at the vaccination center was 40:56 ± 20:52 minutes. The activity that took the longest was 'waiting time in queue before vaccination', which was 34:22 ± 20:56 min constituting 82% of the total time. The activity that took longer for the second dose than the first was the beneficiary verification in the Co-WIN portal with a median of 27 seconds and 36 seconds, respectively (p < .001). This study will help program managers formulate better strategies to improve the vaccination process making it more efficient.
Keywords: COVID-19; policymaking; public health; vaccination.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
References
-
- Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Peacock SJ, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol [Internet]. 2021 Jun 1[accessed 2021 Dec 5];19(7):409–24. doi:10.1038/s41579-021-00573-0. - DOI - PMC - PubMed
-
- Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health [Internet]. [accessed 2021 Dec 5]. https://www.who.int/publications/i/item/9789240018440.
-
- Heaton PM. The Covid-19 vaccine-development multiverse. New Engl J Med [Internet]. 2020. [accessed 2021 Dec 5];383(20):1986–88. https://www.nejm.org/doi/full/ 10.1056/NEJMe2025111. - DOI - PMC - PubMed
-
- Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results | medRxiv [Internet]. [accessed 2020 Nov 14]. https://www.medrxiv.org/content/ 10.1101/2020.10.15.20209817v1. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous